Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
暂无分享,去创建一个
C. Wheeler | H. Kitchener | M. Lehtinen | D. Harper | S. Garland | X. Castellsagué | F. Bosch | F. Aoki | S. Chow | X. Bosch | D. Apter | J. Paavonen | P. Naud | J. Salmerón | S. Skinner | U. Jaisamrarn | G. Limson | F. Struyf | G. Dubin | T. Schwarz | J. Teixeira | A. Szarewski | B. Romanowski | W. Poppe | D. Descamps | W. Huh | T. Zahaf | K. Hardt | Rachel Skinner | S. R. Skinner | Genara Limson